INTERNATIONAL PATENT: SHANGHAI CELL DIFF MEDICINE LIMITED, 上海赛迪夫医药科技有限公司 FILES APPLICATION FOR "SELF-REPLICATING RNA EXPRESSING DIFFERENTIATION-RELATED TRANSCRIPTION FACTOR AND USE THEREOF IN PREPARATION OF TUMOR THERAPEUTIC DRUG"

GENEVA, Nov. 24 -- SHANGHAI CELL DIFF MEDICINE LIMITED (House 33, Hong Qiao State Guest Hotel Shanghai. 1591 Hongqiao RoadChangning District, Shanghai 200336), 上海赛迪夫医药科技有限公司 (中国上海市长宁区虹桥路1591号虹桥迎宾馆33号楼) filed a patent application (PCT/CN2025/094572) for "SELF-REPLICATING RNA EXPRESSING DIFFERENTIATION-RELATED TRANSCRIPTION FACTOR AND USE THEREOF IN PREPARATION OF TUMOR THERAPEUTIC DRUG" on May 13, 2025. With publication no. WO/2025/237287, the details related to the patent application was published on Nov 20, 2025.

Notab...